Q&A: Physicians Weigh Improvements in MASLD Treatment Against Gaps in Assessment Strategies
Physician's Weekly
JUNE 24, 2025
Dr. Srivastava: This study is crucial because it provides robust evidence supporting weight loss as a primary intervention for MASLD. They also nicely summarize drugs in development for MASLD and how various medications work in different ways to benefit the liver. PW: How may this summary affect patient care?
Let's personalize your content